Astellas is a Japanese Pharmaceutical firm specializing in Oncology medication. The environment is changing rapidly as the firm seeks to globalize. The patent cliff approaching will wipe out Bllions of Dollars of revenues for all pharma players


  • This is a heavily regulated and risk averse industry
  • Molecules have traditionally been the focus for innovation
  • There is a need to move to new forms of innovation and transform the organization to become more agile


  • A programme was designed around corporate innovation in the Pharmaceutical sector
  • A special focus was on “Beyond the Pill”innovations
  • Leaders were trained on agile and lean startup methodologies within the corporate environment
  • A rapid innovation framework was embedded in the firm
  • Over a hundred leaders were taken through the programme over a 7 year period